Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
20.56B | 17.54B | 25.29B | 20.50B | 12.42B | 14.97B | Gross Profit |
6.76B | 5.33B | 8.48B | 6.64B | 4.47B | 5.18B | EBIT |
1.21B | 38.55M | 2.66B | 1.85B | 516.95M | 499.58M | EBITDA |
1.63B | 1.75B | 4.04B | 2.84B | 1.67B | 1.31B | Net Income Common Stockholders |
1.05B | -72.80M | 2.29B | 1.57B | 707.17M | -206.22M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
9.03B | 9.03B | 9.53B | 9.77B | 8.66B | 6.04B | Total Assets |
42.95B | 42.95B | 39.51B | 35.13B | 29.85B | 29.72B | Total Debt |
8.01B | 8.01B | 5.28B | 5.22B | 4.89B | 4.82B | Net Debt |
-621.92M | -1.02B | -4.25B | -4.55B | -3.77B | -1.18B | Total Liabilities |
12.35B | 12.35B | 10.31B | 9.77B | 7.78B | 7.98B | Stockholders Equity |
29.61B | 29.61B | 28.30B | 24.60B | 21.38B | 21.07B |
Cash Flow | Free Cash Flow | ||||
0.00 | -1.85B | 213.32M | 1.12B | 1.79B | -980.43M | Operating Cash Flow |
0.00 | 765.57M | 1.86B | 1.88B | 2.26B | 602.81M | Investing Cash Flow |
0.00 | -3.30B | -1.88B | -432.10M | 643.39M | -1.63B | Financing Cash Flow |
0.00 | 1.30B | -1.18B | -673.55M | -145.99M | 576.89M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $45.61B | 16.30 | 2.26% | 5.74% | 22.19% | -22.08% | |
78 Outperform | ¥74.51B | 10.37 | 3.02% | 17.01% | 16.10% | ||
70 Outperform | ¥440.30B | 31.19 | 2.84% | 7.54% | -30.13% | ||
64 Neutral | $4.39B | 12.06 | 5.17% | 249.63% | 4.03% | -11.04% | |
64 Neutral | ¥13.70B | 14.19 | 2.35% | 10.66% | 229.25% | ||
54 Neutral | ¥10.43B | ― | 3.42% | -1.17% | 63.91% |